Demonstration of immunologic memory using serogroup C meningococcal glycoconjugate vaccine.

Ítems similars

• Use of a booster dose of capsular group C meningococcal glycoconjugate vaccine to demonstrate immunologic memory in children primed with one or two vaccine doses in infancy
  per: Pace, D, et al.
  Publicat: (2016)
• Immunologic memory with no detectable bactericidal antibody response to a first dose of meningococcal serogroup C conjugate vaccine at four years.
  per: McVernon, J, et al.
  Publicat: (2003)
• Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X.
  per: Micoli, F, et al.
  Publicat: (2013)
• Serogroup C meningococcal glycoconjugate vaccine in adolescents: persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunization.
  per: Snape, MD, et al.
  Publicat: (2006)
• Serogroup c meningococcal glycoconjugate vaccine in adolescents: persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunization
  per: Snape, M, et al.
  Publicat: (2006)